PER 2.47% 8.3¢ percheron therapeutics limited

Ann: Positive preliminary results from ATL1102 DMD Phase II trial, page-596

  1. 4,680 Posts.
    lightbulb Created with Sketch. 1083
    venBio Select Advisor holds $212.7 million of Sarepta stock.

    Adage Capital Management holds $182.3 million

    These elephants have deep knowledge of the challenges Sarepta faces re FDA efficacy queries.

    They have large positions in Sarepta they need to protect.

    No doubt Goolsbee will be key player going forward as the ANP story unfolds.

    .
    Last edited by Uboy: 16/10/19
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.3¢
Change
0.002(2.47%)
Mkt cap ! $74.82M
Open High Low Value Volume
9.0¢ 9.0¢ 8.2¢ $9.57K 112.6K

Buyers (Bids)

No. Vol. Price($)
2 124862 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 11000 1
View Market Depth
Last trade - 15.56pm 28/03/2024 (20 minute delay) ?
Last
8.2¢
  Change
0.002 ( 0.86 %)
Open High Low Volume
8.2¢ 8.3¢ 8.2¢ 31700
Last updated 15.55pm 28/03/2024 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.